Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase II Trial of Bendamustine Hydrochloride (HCL) in Women With Advanced Ovarian Cancer

NCT00867503 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT00867503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00867503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase II Trial of Bendamustine Hydrochloride (HCL) in Women With Advanced Ovarian Cancer
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
April 30, 2013
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer